top of page
Newsroom Latest News
header4.jpg

Newsroom: Latest News

IGYXOS Initiates Phase 1 Clinical Trials for IGX12: A Breakthrough Treatment for Infertility

NOV16

2023

24

Emmanuel Dulac Appointed as new CEO of Igyxos

JUN20

2023

22

Igyxos selected for the French Tech 120 (FT120) program for the third consecutive year

APR25

2022

21

Igyxos pursues its development and appoints Thierry Ziegler as CMC Chief Operating Officer

MAR15

2021

20

Igyxos and Selexis enter service agreement to advance Igyxos’ first-in-class monoclonal antibody for the treatment of human infertility

SEP02

2020

bottom of page